Bernaschek G, Schaller A
Geburtshilfe Frauenheilkd. 1983 Dec;43(12):755-8. doi: 10.1055/s-2008-1036746.
134 cases of cervical cancer of the clinical stage IIb were examined with regard to the five-year survival rate. The report covers the time from 1964 to 1976. The patients had either been operated on primarily or had primarily undergone irradiation treatment. The five-year survival rates for the first group amount to 57.69% (n = 78), for the second group to 42.86% (n = 56). This difference is not significant under the restriction of limited comparability because of the different age of the patients. 65.38% (abs.: 51 from 78) of the operated cases turned out to be clinically overestimated cases of cervical cancer of the histological stages Ib, Ic and IIa. 27 cases belonged to the clinical and histological stage IIb and for this group of patients the five-year survival rate was 29.62% only. This and a number of other factors--the narrowing of the site of the operation with the growing danger for the ureter, increasingly affected lymphatic nodes--would justify restraint concerning surgical treatment of stage IIb.
对134例临床IIb期宫颈癌患者的五年生存率进行了检查。报告涵盖了1964年至1976年的时间段。这些患者要么接受了初次手术，要么主要接受了放射治疗。第一组的五年生存率为57.69%（n = 78），第二组为42.86%（n = 56）。由于患者年龄不同，在可比性有限的限制下，这种差异不显著。65.38%（绝对值：78例中的51例）接受手术的病例被证明是组织学分期为Ib、Ic和IIa期的宫颈癌临床高估病例。27例属于临床和组织学IIb期，该组患者的五年生存率仅为29.62%。这一点以及其他一些因素——随着输尿管危险增加手术部位变窄、淋巴结受影响越来越多——证明在IIb期手术治疗方面应持谨慎态度。
